Medpace Holdings Stock Tumbles On Q2 Earnings: What Investors Need To Know
Portfolio Pulse from Adam Eckert
Medpace Holdings Inc (NASDAQ:MEDP) shares fell in after-hours trading following mixed Q2 financial results and a revision of forward guidance. The company reported Q2 revenue of $528.1 million, slightly below estimates, and EPS of $2.75, above estimates. Medpace revised its full-year 2024 revenue forecast downward but raised its earnings outlook. Shares were down 13.08% at $380.
July 22, 2024 | 9:08 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Medpace Holdings Inc (NASDAQ:MEDP) reported mixed Q2 results with revenue slightly missing estimates but EPS beating expectations. The company revised its full-year 2024 revenue forecast downward but raised its earnings outlook. Shares fell 13.08% in after-hours trading.
The mixed Q2 results, with revenue slightly missing estimates and EPS beating expectations, along with the downward revision of the full-year revenue forecast, have led to a significant drop in Medpace's share price. The raised earnings outlook was not enough to offset the negative sentiment from the revenue miss and lowered guidance.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100